BORTEZOMIB (BORTEZOMIB) — FDA Approval NDA212782 (SHILPA)
BORTEZOMIB (BORTEZOMIB) — FDA Approval NDA212782 (SHILPA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BORTEZOMIB; Active ingredients: BORTEZOMIB; Application number: NDA212782.
| Brand name | BORTEZOMIB |
|---|---|
| Active ingredients | BORTEZOMIB |
| Application number | NDA212782 |
| Sponsor | SHILPA |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS, SUBCUTANEOUS |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20240826 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →